237 related articles for article (PubMed ID: 27046040)
1. Phosphorylated Heat Shock Protein 20 (HSPB6) Regulates Transforming Growth Factor-α-Induced Migration and Invasion of Hepatocellular Carcinoma Cells.
Matsushima-Nishiwaki R; Toyoda H; Nagasawa T; Yasuda E; Chiba N; Okuda S; Maeda A; Kaneoka Y; Kumada T; Kozawa O
PLoS One; 2016; 11(4):e0151907. PubMed ID: 27046040
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein 20 (HSPB6) regulates TNF-α-induced intracellular signaling pathway in human hepatocellular carcinoma cells.
Nagasawa T; Matsushima-Nishiwaki R; Yasuda E; Matsuura J; Toyoda H; Kaneoka Y; Kumada T; Kozawa O
Arch Biochem Biophys; 2015 Jan; 565():1-8. PubMed ID: 25447820
[TBL] [Abstract][Full Text] [Related]
3. Heat shock protein 22 (HSPB8) reduces the migration of hepatocellular carcinoma cells through the suppression of the phosphoinositide 3-kinase (PI3K)/AKT pathway.
Matsushima-Nishiwaki R; Toyoda H; Takamatsu R; Yasuda E; Okuda S; Maeda A; Kaneoka Y; Yoshimi N; Kumada T; Kozawa O
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1629-1639. PubMed ID: 28456666
[TBL] [Abstract][Full Text] [Related]
4. Direct association of heat shock protein 20 (HSPB6) with phosphoinositide 3-kinase (PI3K) in human hepatocellular carcinoma: regulation of the PI3K activity.
Matsushima-Nishiwaki R; Kumada T; Nagasawa T; Suzuki M; Yasuda E; Okuda S; Maeda A; Kaneoka Y; Toyoda H; Kozawa O
PLoS One; 2013; 8(11):e78440. PubMed ID: 24223153
[TBL] [Abstract][Full Text] [Related]
5. Suppression by heat shock protein 20 of hepatocellular carcinoma cell proliferation via inhibition of the mitogen-activated protein kinases and AKT pathways.
Matsushima-Nishiwaki R; Adachi S; Yoshioka T; Yasuda E; Yamagishi Y; Matsuura J; Muko M; Iwamura R; Noda T; Toyoda H; Kaneoka Y; Okano Y; Kumada T; Kozawa O
J Cell Biochem; 2011 Nov; 112(11):3430-9. PubMed ID: 21769911
[TBL] [Abstract][Full Text] [Related]
6. Heat shock protein 20 (HSPB6) regulates apoptosis in human hepatocellular carcinoma cells: Direct association with Bax.
Nagasawa T; Matsushima-Nishiwaki R; Toyoda H; Matsuura J; Kumada T; Kozawa O
Oncol Rep; 2014 Sep; 32(3):1291-5. PubMed ID: 24969689
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-294 Promotes Cell Proliferation, Migration and Invasion in SMMC-7721 Hepatoma Carcinoma Cells by Activating the JNK/ERK Signaling Pathway.
Cheng X; Chen M; Liu Z
Am J Med Sci; 2020 Jun; 359(6):365-371. PubMed ID: 32498943
[TBL] [Abstract][Full Text] [Related]
8. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
Hsieh SC; Tsai JP; Yang SF; Tang MJ; Hsieh YH
Amino Acids; 2014 Dec; 46(12):2809-22. PubMed ID: 25245054
[TBL] [Abstract][Full Text] [Related]
9. Heat shock protein 22 (HSPB8) limits TGF-β-stimulated migration of osteoblasts.
Yamamoto N; Tokuda H; Kuroyanagi G; Kainuma S; Matsushima-Nishiwaki R; Fujita K; Kozawa O; Otsuka T
Mol Cell Endocrinol; 2016 Nov; 436():1-9. PubMed ID: 27396899
[TBL] [Abstract][Full Text] [Related]
10. Hypo-phosphorylated CD147 promotes migration and invasion of hepatocellular carcinoma cells and predicts a poor prognosis.
Jin J; Wang SJ; Cui J; Li L; Li JY; Liu FL; Sun XX; Jiang JL; Cui HY; Chen ZN
Cell Oncol (Dordr); 2019 Aug; 42(4):537-554. PubMed ID: 31016558
[TBL] [Abstract][Full Text] [Related]
11. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
[TBL] [Abstract][Full Text] [Related]
12. Quercetin suppresses the migration of hepatocellular carcinoma cells stimulated by hepatocyte growth factor or transforming growth factor-α: Attenuation of AKT signaling pathway.
Yamada N; Matsushima-Nishiwaki R; Kozawa O
Arch Biochem Biophys; 2020 Mar; 682():108296. PubMed ID: 32032576
[TBL] [Abstract][Full Text] [Related]
13. miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway.
Yang F; Yin Y; Wang F; Wang Y; Zhang L; Tang Y; Sun S
Hepatology; 2010 May; 51(5):1614-23. PubMed ID: 20209605
[TBL] [Abstract][Full Text] [Related]
14. SERMs (selective estrogen receptor modulator), acting as estrogen receptor β agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-α-induced migration via specific inhibition of AKT signaling pathway.
Matsushima-Nishiwaki R; Yamada N; Hattori Y; Hosokawa Y; Tachi J; Hori T; Kozawa O
PLoS One; 2022; 17(1):e0262485. PubMed ID: 35007301
[TBL] [Abstract][Full Text] [Related]
15. GLP-1 reduces the migration of hepatocellular carcinoma cells via suppression of the stress-activated protein kinase/c-Jun N-terminal kinase pathway.
Yamada N; Matsushima-Nishiwaki R; Kobayashi K; Tachi J; Kozawa O
Arch Biochem Biophys; 2021 May; 703():108851. PubMed ID: 33771507
[TBL] [Abstract][Full Text] [Related]
16. Regulation of HSP27 on NF-kappaB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis.
Guo K; Kang NX; Li Y; Sun L; Gan L; Cui FJ; Gao MD; Liu KY
BMC Cancer; 2009 Mar; 9():100. PubMed ID: 19331697
[TBL] [Abstract][Full Text] [Related]
17. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma.
Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP
Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552
[TBL] [Abstract][Full Text] [Related]
18. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.
Li Q; Liu G; Shao D; Wang J; Yuan H; Chen T; Zhai R; Ni W; Tai G
Int J Biochem Cell Biol; 2015 Feb; 59():116-25. PubMed ID: 25526895
[TBL] [Abstract][Full Text] [Related]
19. Upregulation by duloxetine of the transforming growth factor-α-induced migration of hepatocellular carcinoma cells via enhancement of the c-Jun N-terminal kinase activity.
Matsushima-Nishiwaki R; Kamoi S; Kozawa O
Cell Biochem Funct; 2023 Oct; 41(7):814-822. PubMed ID: 37814477
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway.
Geng D; Zhao W; Feng Y; Liu J
Tumour Biol; 2016 Mar; 37(3):3341-7. PubMed ID: 26443539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
